nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—urine—polycystic ovary syndrome	0.0273	0.14	CbGeAlD
Guanfacine—CYP2C9—urine—polycystic ovary syndrome	0.0212	0.109	CbGeAlD
Guanfacine—Upset stomach—Metformin—polycystic ovary syndrome	0.0178	0.0786	CcSEcCtD
Guanfacine—CYP3A4—urine—polycystic ovary syndrome	0.0161	0.0828	CbGeAlD
Guanfacine—NISCH—adrenal cortex—polycystic ovary syndrome	0.0149	0.0765	CbGeAlD
Guanfacine—NISCH—uterus—polycystic ovary syndrome	0.0123	0.0629	CbGeAlD
Guanfacine—NISCH—pituitary gland—polycystic ovary syndrome	0.012	0.0618	CbGeAlD
Guanfacine—NISCH—adipose tissue—polycystic ovary syndrome	0.012	0.0616	CbGeAlD
Guanfacine—NISCH—adrenal gland—polycystic ovary syndrome	0.0108	0.0552	CbGeAlD
Guanfacine—NISCH—female gonad—polycystic ovary syndrome	0.01	0.0515	CbGeAlD
Guanfacine—NISCH—vagina—polycystic ovary syndrome	0.00997	0.0512	CbGeAlD
Guanfacine—Lethargy—Metformin—polycystic ovary syndrome	0.00866	0.0381	CcSEcCtD
Guanfacine—Pain in extremity—Metformin—polycystic ovary syndrome	0.00849	0.0374	CcSEcCtD
Guanfacine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00783	0.0345	CcSEcCtD
Guanfacine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00775	0.0341	CcSEcCtD
Guanfacine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00703	0.031	CcSEcCtD
Guanfacine—Drowsiness—Metformin—polycystic ovary syndrome	0.00654	0.0288	CcSEcCtD
Guanfacine—Bradycardia—Metformin—polycystic ovary syndrome	0.00598	0.0263	CcSEcCtD
Guanfacine—Rhinitis—Metformin—polycystic ovary syndrome	0.00588	0.0259	CcSEcCtD
Guanfacine—Eye disorder—Metformin—polycystic ovary syndrome	0.00549	0.0242	CcSEcCtD
Guanfacine—Immune system disorder—Metformin—polycystic ovary syndrome	0.0053	0.0234	CcSEcCtD
Guanfacine—Dysgeusia—Metformin—polycystic ovary syndrome	0.005	0.022	CcSEcCtD
Guanfacine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00491	0.0216	CcSEcCtD
Guanfacine—ADRA2A—endometrium—polycystic ovary syndrome	0.00485	0.0249	CbGeAlD
Guanfacine—CYP2C19—vagina—polycystic ovary syndrome	0.00484	0.0248	CbGeAlD
Guanfacine—Vision blurred—Metformin—polycystic ovary syndrome	0.00482	0.0212	CcSEcCtD
Guanfacine—Tremor—Metformin—polycystic ovary syndrome	0.00479	0.0211	CcSEcCtD
Guanfacine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00474	0.0209	CcSEcCtD
Guanfacine—Malaise—Metformin—polycystic ovary syndrome	0.00461	0.0203	CcSEcCtD
Guanfacine—Syncope—Metformin—polycystic ovary syndrome	0.00458	0.0202	CcSEcCtD
Guanfacine—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00453	0.0232	CbGeAlD
Guanfacine—Palpitations—Metformin—polycystic ovary syndrome	0.00452	0.0199	CcSEcCtD
Guanfacine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00449	0.0198	CcSEcCtD
Guanfacine—ADRA2A—uterus—polycystic ovary syndrome	0.00447	0.0229	CbGeAlD
Guanfacine—Hypertension—Metformin—polycystic ovary syndrome	0.00441	0.0194	CcSEcCtD
Guanfacine—ADRA2A—pituitary gland—polycystic ovary syndrome	0.00439	0.0225	CbGeAlD
Guanfacine—ADRA2A—adipose tissue—polycystic ovary syndrome	0.00437	0.0224	CbGeAlD
Guanfacine—Myalgia—Metformin—polycystic ovary syndrome	0.00435	0.0192	CcSEcCtD
Guanfacine—Chest pain—Metformin—polycystic ovary syndrome	0.00435	0.0192	CcSEcCtD
Guanfacine—Discomfort—Metformin—polycystic ovary syndrome	0.0043	0.0189	CcSEcCtD
Guanfacine—Oedema—Metformin—polycystic ovary syndrome	0.00417	0.0184	CcSEcCtD
Guanfacine—Shock—Metformin—polycystic ovary syndrome	0.0041	0.0181	CcSEcCtD
Guanfacine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00403	0.0178	CcSEcCtD
Guanfacine—ADRA2A—adrenal gland—polycystic ovary syndrome	0.00392	0.0201	CbGeAlD
Guanfacine—Hypotension—Metformin—polycystic ovary syndrome	0.0039	0.0172	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0038	0.0167	CcSEcCtD
Guanfacine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00374	0.0165	CcSEcCtD
Guanfacine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00372	0.0164	CcSEcCtD
Guanfacine—Somnolence—Metformin—polycystic ovary syndrome	0.00371	0.0163	CcSEcCtD
Guanfacine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00367	0.0162	CcSEcCtD
Guanfacine—ADRA2A—female gonad—polycystic ovary syndrome	0.00366	0.0188	CbGeAlD
Guanfacine—ADRA2A—vagina—polycystic ovary syndrome	0.00363	0.0186	CbGeAlD
Guanfacine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00363	0.016	CcSEcCtD
Guanfacine—Fatigue—Metformin—polycystic ovary syndrome	0.0036	0.0158	CcSEcCtD
Guanfacine—Constipation—Metformin—polycystic ovary syndrome	0.00357	0.0157	CcSEcCtD
Guanfacine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00351	0.018	CbGeAlD
Guanfacine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00344	0.0151	CcSEcCtD
Guanfacine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00341	0.015	CcSEcCtD
Guanfacine—ADRA2A—endocrine gland—polycystic ovary syndrome	0.0034	0.0175	CbGeAlD
Guanfacine—Abdominal pain—Metformin—polycystic ovary syndrome	0.0033	0.0145	CcSEcCtD
Guanfacine—Asthenia—Metformin—polycystic ovary syndrome	0.00299	0.0132	CcSEcCtD
Guanfacine—Pruritus—Metformin—polycystic ovary syndrome	0.00295	0.013	CcSEcCtD
Guanfacine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00285	0.0126	CcSEcCtD
Guanfacine—Dizziness—Metformin—polycystic ovary syndrome	0.00276	0.0121	CcSEcCtD
Guanfacine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00268	0.0137	CbGeAlD
Guanfacine—Vomiting—Metformin—polycystic ovary syndrome	0.00265	0.0117	CcSEcCtD
Guanfacine—Rash—Metformin—polycystic ovary syndrome	0.00263	0.0116	CcSEcCtD
Guanfacine—Dermatitis—Metformin—polycystic ovary syndrome	0.00263	0.0116	CcSEcCtD
Guanfacine—Headache—Metformin—polycystic ovary syndrome	0.00261	0.0115	CcSEcCtD
Guanfacine—Nausea—Metformin—polycystic ovary syndrome	0.00248	0.0109	CcSEcCtD
Guanfacine—ADRA2A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000252	0.000436	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000252	0.000436	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000249	0.00043	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000248	0.00043	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—STAR—polycystic ovary syndrome	0.000248	0.000429	CbGpPWpGaD
Guanfacine—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000248	0.000428	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000243	0.000421	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000243	0.00042	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000243	0.00042	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—GNAS—polycystic ovary syndrome	0.00024	0.000415	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000238	0.000412	CbGpPWpGaD
Guanfacine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000237	0.000411	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000237	0.000409	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000236	0.000408	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000236	0.000408	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000232	0.000401	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000232	0.000401	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000229	0.000396	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000229	0.000396	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000227	0.000392	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000223	0.000385	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000223	0.000385	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000223	0.000385	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—HMMR—polycystic ovary syndrome	0.000221	0.000382	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000219	0.000379	CbGpPWpGaD
Guanfacine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000219	0.000379	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000217	0.000376	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FST—polycystic ovary syndrome	0.000217	0.000375	CbGpPWpGaD
Guanfacine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000216	0.000374	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000216	0.000373	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000215	0.000372	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000214	0.000371	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LHB—polycystic ovary syndrome	0.000212	0.000366	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000211	0.000365	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000211	0.000365	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—HSD3B1—polycystic ovary syndrome	0.000211	0.000364	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000207	0.000358	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—IGF1—polycystic ovary syndrome	0.000205	0.000354	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—AKT2—polycystic ovary syndrome	0.000205	0.000354	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000203	0.000351	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000203	0.000351	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.0002	0.000347	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.0002	0.000346	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.0002	0.000346	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000198	0.000343	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000198	0.000342	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000197	0.000341	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000196	0.000339	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000195	0.000337	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000194	0.000336	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000193	0.000333	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—LHB—polycystic ovary syndrome	0.000192	0.000332	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000189	0.000327	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—HSD3B2—polycystic ovary syndrome	0.000188	0.000325	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000186	0.000322	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000185	0.000319	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000184	0.000319	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000184	0.000318	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKR1C1—polycystic ovary syndrome	0.000182	0.000315	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000182	0.000314	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000181	0.000313	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00018	0.000311	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000177	0.000306	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000176	0.000305	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000176	0.000305	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000176	0.000304	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000174	0.0003	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000174	0.0003	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000172	0.000298	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00017	0.000294	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000169	0.000292	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000168	0.00029	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	0.000167	0.000289	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000165	0.000285	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000164	0.000283	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000164	0.000283	CbGpPWpGaD
Guanfacine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000163	0.000282	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000163	0.000281	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000162	0.000281	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	0.000162	0.00028	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000161	0.000278	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.00016	0.000277	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000158	0.000274	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000157	0.000272	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000156	0.000271	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	0.000156	0.00027	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	0.000156	0.000269	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	0.000155	0.000269	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000154	0.000267	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000152	0.000263	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000152	0.000263	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000152	0.000262	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000151	0.00026	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PGR—polycystic ovary syndrome	0.00015	0.00026	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	0.00015	0.00026	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000149	0.000258	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000149	0.000257	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	0.000148	0.000256	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000148	0.000255	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000148	0.000255	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000144	0.000248	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000143	0.000247	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000141	0.000244	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	0.00014	0.000242	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00014	0.000242	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00014	0.000242	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00014	0.000242	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00014	0.000242	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000139	0.000241	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000139	0.000241	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	0.000138	0.000238	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000138	0.000238	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000136	0.000235	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000136	0.000235	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000135	0.000233	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000135	0.000233	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—VEGFA—polycystic ovary syndrome	0.000134	0.000232	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000133	0.000231	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000133	0.00023	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000131	0.000226	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00013	0.000225	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000129	0.000224	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000129	0.000223	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000129	0.000223	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000128	0.000221	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000124	0.000215	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000123	0.000213	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000123	0.000213	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000122	0.000211	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000122	0.000211	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000121	0.00021	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—TH—polycystic ovary syndrome	0.000119	0.000206	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	0.000119	0.000205	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000118	0.000203	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000117	0.000203	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000117	0.000202	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000117	0.000202	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	0.000116	0.000201	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000116	0.0002	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000115	0.000199	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	0.000115	0.000199	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000114	0.000197	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	0.000111	0.000191	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000111	0.000191	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	0.000109	0.000189	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000108	0.000187	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000107	0.000186	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	0.000106	0.000184	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000106	0.000183	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000106	0.000183	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000106	0.000183	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000106	0.000183	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	0.000105	0.000182	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000105	0.000181	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000104	0.00018	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000102	0.000177	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000102	0.000177	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	0.000102	0.000176	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000101	0.000175	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000101	0.000175	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	0.0001	0.000174	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	9.92e-05	0.000172	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.87e-05	0.000171	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.82e-05	0.00017	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	9.76e-05	0.000169	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	9.73e-05	0.000168	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	9.7e-05	0.000168	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.64e-05	0.000167	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	9.58e-05	0.000166	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.51e-05	0.000164	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	9.41e-05	0.000163	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	9.34e-05	0.000161	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	9.28e-05	0.00016	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	9.27e-05	0.00016	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	9.25e-05	0.00016	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	9.04e-05	0.000156	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.97e-05	0.000155	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.92e-05	0.000154	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	8.9e-05	0.000154	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	8.79e-05	0.000152	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.78e-05	0.000152	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	8.59e-05	0.000149	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—TH—polycystic ovary syndrome	8.45e-05	0.000146	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	8.41e-05	0.000145	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	8.22e-05	0.000142	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	8.2e-05	0.000142	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.18e-05	0.000142	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	8.14e-05	0.000141	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8e-05	0.000138	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.75e-05	0.000134	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.75e-05	0.000134	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	7.73e-05	0.000134	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	7.7e-05	0.000133	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	7.61e-05	0.000132	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	7.5e-05	0.00013	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	7.49e-05	0.00013	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	7.22e-05	0.000125	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	7.18e-05	0.000124	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.13e-05	0.000123	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	7.05e-05	0.000122	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	6.95e-05	0.00012	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	6.94e-05	0.00012	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.91e-05	0.000119	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	6.9e-05	0.000119	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.66e-05	0.000115	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	6.65e-05	0.000115	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.6e-05	0.000114	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	6.57e-05	0.000114	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	6.55e-05	0.000113	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	6.52e-05	0.000113	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—INS—polycystic ovary syndrome	6.52e-05	0.000113	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.4e-05	0.000111	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	6.38e-05	0.00011	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.32e-05	0.000109	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	6.29e-05	0.000109	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	6.23e-05	0.000108	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	5.99e-05	0.000104	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.96e-05	0.000103	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.87e-05	0.000102	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	5.81e-05	0.0001	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	5.69e-05	9.84e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	5.68e-05	9.82e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	5.48e-05	9.48e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	5.45e-05	9.43e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	5.31e-05	9.19e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	5.29e-05	9.16e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.27e-05	9.12e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.27e-05	9.11e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.08e-05	8.79e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.01e-05	8.66e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.94e-05	8.55e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	4.71e-05	8.14e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.65e-05	8.04e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	4.64e-05	8.03e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	4.62e-05	7.99e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.54e-05	7.85e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	4.29e-05	7.43e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	4.23e-05	7.32e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	4.21e-05	7.28e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.15e-05	7.17e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.03e-05	6.97e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.95e-05	6.83e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.75e-05	6.48e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.49e-05	6.04e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.44e-05	5.96e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	3.14e-05	5.43e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.83e-05	4.9e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.79e-05	4.83e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.78e-05	4.8e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.38e-05	4.12e-05	CbGpPWpGaD
